Beckman Coulter, Inc.
Clinical trials sponsored by Beckman Coulter, Inc., explained in plain language.
A diagnostics company providing laboratory instruments and reagents.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New hepatitis b blood tests put to the test on 21,000 samples
Diagnosis CompletedThis study checked how well new blood tests (Access HBV assays) can detect hepatitis B infection. Researchers tested over 21,000 leftover blood samples from adults, including blood donors and hospital patients. The goal was to see if these tests are accurate compared to existing …
Sponsor: Beckman Coulter, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
New BNP blood test could improve heart failure diagnosis
Diagnosis CompletedThis study tested a new BNP blood test on 1,361 people to see how well it identifies heart failure. The test measures a substance in the blood that can indicate heart strain. Researchers compared the test results to standard methods to check accuracy. The goal is to give doctors …
Sponsor: Beckman Coulter, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC